In addition to those conditions mentioned above, dihydroergotamine mesylate nasal spray is also contraindicated in patients with known peripheral arterial disease, sepsis, following vascular surgery, and severely impaired hepatic or renal function
investigated -MSH-derived peptides including KPV for their anti-inflammatory properties and inhibition of NF-B-dependent cytokine pathways
Thomas Gates, then McNeils medical director, shot off a memo to the chief executive of Johnson & Johnson, the president of McNeil and other top officials, laying out a detailed plan of action for diffusing media interest in the research and limiting the extent and duration of the coverage. Gates envisioned two possibilities: Low Level of Publicity (most probable scenario) and High Level of Publicity (worst case scenario). For the latter, Gates suggested a series of responses: a letter-writing campaign to medical societies, doctors, pharmacists and academics
Yet, some other studies have reported no overall benefit of OXT treatment for 312 years old children